收藏切换
Effect of roxallistat assisted erythropoietin on renal anemia patients and its effect on transferrin and transferrin saturation
收藏切换
Yongbiao YANG1, Guanggui DING1, Meng HE1, Jie ZHONG1, Xueping WU2, *
World Clinical Drug | 2024, 45(9) : 957 - 961
Less
收藏切换
World Clinical Drug | 2024, 45(9): 957-961
• Article •
Effect of roxallistat assisted erythropoietin on renal anemia patients and its effect on transferrin and transferrin saturation
Full
Yongbiao YANG1, Guanggui DING1, Meng HE1, Jie ZHONG1, Xueping WU2, *
Affiliations
  • 1.Department of Nephrology, Mingguang People's Hospital, Chuzhou 239400, Anhui Province, China
  • 2.Department of Nephrology, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, Anhui Province, China
Published: 2024-09-10 doi: 10.13683/j.wph.2024.09.010
Outline
收藏切换
Objective

To investigate the effect of roxallistat assisted erythropoietin (EPO) on patients with renal anemia (RA) and its effect on transferrin (TRF) and TRF saturation (TSAT) levels.

Methods

A total of 179 RA patients treated in the department of nephrology, Mingguang people's hospital from January 2021 to December 2023 were selected and divided into experimental group (n=90, EPO+roxallistat) and control group (n=89, EPO) by random number table method. Both groups were treated for 12 months. The clinical efficacy, TRF, TSAT, serum indexes of anemia [red blood cell (RBC), hemoglobin (Hb), serum ferritin (SF)] and the incidence of adverse reactions were compared between the two groups.

Results

After treatment, the clinical effective rate of experimental group was higher than that of control group (91.11% vs 79.78%, P<0.05). The levels of TRF, TSAT, RBC, Hb and SF in both groups were higher than before (P<0.05), and the experimental group was higher than the control group (P<0.05). The incidence of adverse reactions in experimental group and control group was 6.67% and 10.11%, respectively, with no significant difference (P>0.05).

Conclusion

Roxallistat assisted EPO in the treatment of RA is effective, and can improve the level of TRF, TSAT and anemia.

roxallistat  /  erythropoietin  /  renal anemia  /  transferrin  /  transferrin saturation
杨永彪, 丁广贵, 何猛, 钟颉, 吴雪平. 罗沙司他辅助促红细胞生成素对肾性贫血患者疗效及对转铁蛋白、转铁蛋白饱和度的影响. 世界临床药物, 2024 , 45 (9) : 957 -961 . DOI: 10.13683/j.wph.2024.09.010
Yongbiao YANG, Guanggui DING, Meng HE, Jie ZHONG, Xueping WU. Effect of roxallistat assisted erythropoietin on renal anemia patients and its effect on transferrin and transferrin saturation[J]. World Clinical Drug, 2024 , 45 (9) : 957 -961 . DOI: 10.13683/j.wph.2024.09.010
Year 2024 volume 45 Issue 9
8
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.09.010
  • Receive Date:2024-08-11
  • Online Date:2026-11-17
  • Published:2024-09-10
Article Data
Affiliations
History
  • Received:2024-08-11
Affiliations
    1.Department of Nephrology, Mingguang People's Hospital, Chuzhou 239400, Anhui Province, China
    2.Department of Nephrology, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, Anhui Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.09.010
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT